LANTERN PHARMA INC. (LTRN) Stock buybacks 2022–2024
LANTERN PHARMA INC. (LTRN) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$499,997FY2024 · since FY2022: $939,666 → $499,997
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $499,997 | -79.9% |
| FY2023 | $2.5M | +164.2% |
| FY2022 | $939,666 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LTRN financial trends
LTRN RevenueLTRN Net incomeLTRN Net marginLTRN Gross profitLTRN Gross marginLTRN Operating incomeLTRN Operating marginLTRN Operating cash flowLTRN Free cash flowLTRN Capital expendituresLTRN Return on equityLTRN Dividends paidLTRN Total assetsLTRN Total liabilitiesLTRN Shareholders’ equityLTRN overview →